1.00Open1.00Pre Close0 Volume37 Open Interest17.50Strike Price0.00Turnover136.67%IV7.00%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type0.5026Delta0.1458Gamma17.29Leverage Ratio-0.1188Theta0.0010Rho8.69Eff Leverage0.0080Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet